Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    P28 - Locally Advanced Non-Small Cell Lung Cancer - Post PACIFIC Use of Durvalumab

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locally Advanced Non-Small Cell Lung Cancer
    • +

      P28.01 - Real-World Experience (RWE) of Consolidation Durvalumab After Concurrent Chemoradiotherapy (CCRT) In Stage III NSCLC

      00:00 - 00:00  |  Presenter: Yiqing Huang

      • Abstract

      Loading...

  • +

    P48 - Novel Therapeutics and Targeted Therapies - EGFR

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      P48.06 - A Network Meta-Analysis (MA) of First-Line Lung Cancer Treatment With Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)

      00:00 - 00:00  |  Presenter: Yvonne Ang

      • Abstract

      Loading...

  • +

    P51 - Novel Therapeutics and Targeted Therapies - EGFR Resistance

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      P51.01 - Tepotinib Plus an EGFR TKI in Patients with EGFR-mutant NSCLC and Resistance to EGFR TKIs Due to MET Amplification (METamp)

      00:00 - 00:00  |  Presenter: Chong Kin Liam

      • Abstract

      Loading...

  • +

    ES02 - Multidisciplinary Collaboration in the Treatment of Oligometastatic Disease*

    • 08:15 - 08:50
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Multimodality of Advanced Lung Cancer
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES02.01 - Overview of Oligometastatic Disease

      08:15 - 08:17  |  Presenter: Ross Soo

      • Abstract

      No abstract available for this presentation

  • +

    MA12 - The Impact of COVID-19 on How We Treat Thoracic Cancer Now and in the Future

    • 20:00 - 21:00
    • 9/12/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      MA12.03 - A Thoracic Cancers International COVID 19 Collaboration Survey on Patients’ Perceptions of COVID-19 (Teravolt-Paper)

      20:10 - 20:15  |  Presenter: Selina K Wong

      • Abstract

      Loading...

  • +

    OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic

    • 20:00 - 21:00
    • 9/12/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Nursing and Allied Health Professionals
    • +

      OA17.04 - The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers

      20:30 - 20:40  |  Presenter: Anne-Marie Baird

      • Abstract

      Loading...